Yaoji Wang1, Pingping Cao1. 1. The First Department of Respiratory Medicine, The First People's Hospital of Wenling Wenling 317000, Zhejiang Province, China.
Abstract
PURPOSE: The aim of this study was to summarize the care modalities, experiences, and corresponding precautions of ECMO for acute exacerbations of chronic obstructive pulmonary disease (COPD). METHODS: Seventy-three patients with acute exacerbations of COPD were enrolled, of whom 38 were treated with ECMO (experimental group) and 35 received conventional low-flow oxygen therapy, management of metabolic acidosis, infection control, bronchodilators for quick relief from severe spasms, and glucocorticoid-mediated suppression of inflammation (control group). The improvement in the patient's pulmonary ventilation and the incidence of complications were recorded. RESULTS: PaCO2 is lower in patients using ECMO, FEV1, FEV1/FVC, and FEV1% are significantly higher in the experimental group than in the control group, and the respiratory rate, heart rate, and CO2 saturation are significantly lower in patients in the experimental group (i.e., the experimental group) after oxygenation than in the control group, pH and O2 saturation are significantly higher in experimental group than in the control group, and the incidence of complications in experimental group is significantly higher than in the control group. CONCLUSION: ECMO significantly improves gas exchange in patients, but also increases the incidence of complications with the extension of usage, so the duration of ECMO support should be monitored and the complications should be prevented. AJTR
PURPOSE: The aim of this study was to summarize the care modalities, experiences, and corresponding precautions of ECMO for acute exacerbations of chronic obstructive pulmonary disease (COPD). METHODS: Seventy-three patients with acute exacerbations of COPD were enrolled, of whom 38 were treated with ECMO (experimental group) and 35 received conventional low-flow oxygen therapy, management of metabolic acidosis, infection control, bronchodilators for quick relief from severe spasms, and glucocorticoid-mediated suppression of inflammation (control group). The improvement in the patient's pulmonary ventilation and the incidence of complications were recorded. RESULTS: PaCO2 is lower in patients using ECMO, FEV1, FEV1/FVC, and FEV1% are significantly higher in the experimental group than in the control group, and the respiratory rate, heart rate, and CO2 saturation are significantly lower in patients in the experimental group (i.e., the experimental group) after oxygenation than in the control group, pH and O2 saturation are significantly higher in experimental group than in the control group, and the incidence of complications in experimental group is significantly higher than in the control group. CONCLUSION: ECMO significantly improves gas exchange in patients, but also increases the incidence of complications with the extension of usage, so the duration of ECMO support should be monitored and the complications should be prevented. AJTR
Authors: Whittney A Warren; Domingo Franco-Palacios; Christopher S King; Oksana A Shlobin; Steven D Nathan; Shalika B Katugaha; Haresh Mani; A Whitney Brown Journal: Chest Date: 2018-03 Impact factor: 9.410
Authors: Dongfang Wang; Scott Lick; Scott K Alpard; Donald J Deyo; Clare Savage; Alex Duarte; Sean Chambers; Joseph B Zwischenberger Journal: ASAIO J Date: 2003 Sep-Oct Impact factor: 2.872
Authors: Stephan Strassmann; Michaela Merten; Simone Schäfer; Jonas de Moll; Daniel Brodie; Anders Larsson; Wolfram Windisch; Christian Karagiannidis Journal: Intensive Care Med Exp Date: 2019-03-25